Non-Invasive Respiratory Therapy Market
完整報告名稱與涵蓋範圍
Non-Invasive Respiratory Therapy Market Size, Share & Trends Analysis Report By Product (Non-invasive Positive-pressure Ventilator (PPV), Non-invasive Negative Pressure Ventilator (NPV)), By Application (Respiratory Distress Syndrome, Asthma & COPD, Others), By End-Use, By Region, And By Segment Forecasts, 2025-2034
報告摘要
Valued at USD 2.45 Bn as of 2024, the global Non-Invasive Respiratory Therapy Market is poised to climb to USD 4.04 Bn by 2034, reflecting a compound annual growth rate of 5.2% over the 2025–2034 period.
Non-Invasive Respiratory Therapy covers treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Non-Invasive Respiratory Therapy Market Snapshot
Chapter 4. Global Non-Invasive Respiratory Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Non-invasive Positive-pressure Ventilator (PPV)
5.2.1.1. Bi-level Positive Airway Pressure Ventilator (BiPAP)
5.2.1.2. Constant Positive Airway Pressure Ventilator (CPAP)
5.2.1.3. Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)
5.2.2. Non-invasive Negative-pressure Ventilator (PPV)
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Respiratory Distress Syndrome
6.2.2. Asthma & Chronic Obstructive Pulmonary Disease (COPD)
6.2.3. Others
Chapter 7. Market Segmentation 3: By End-use Estimates & Trend Analysis
7.1. By End-use & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-use:
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers (ASCs)
7.2.3. Others
Chapter 8. Non-Invasive Respiratory Therapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
8.1.2. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By End-use, 2021-2034
8.1.4. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2021-2034
8.2.2. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2021-2034
8.2.4. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2021-2034
8.3.2. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2021-2034
8.3.4. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
8.4.2. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.4.4. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ResMed Inc.
9.2.2. Teleflex Incorporated
9.2.3. Hamilton Medical
9.2.4. Koninklijke Philips N.V.
9.2.5. Heyer Medical AG
9.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.2.7. Airon Corporation, Drägerwerk AG & Co. KGaA
9.2.8. Fisher & Paykel Healthcare Limited
9.2.9. Baxter International
9.2.10. WILAmed GmbH
9.2.11. Getinge AB
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們